Solid Biosciences Financials - Benzinga

Solid Biosciences Inc

SLDBNASDAQ

Trade with Public

Trade with Public

$8.02

-0.90-10.09%

At close: Sep 23, 5:00 PM EST

$8.08

0.060.75%

After Hours: 4:27 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

Solid Biosciences Financials

Solid Biosciences (SLDB) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Solid Biosciences Q2 EPS $(0.38) Beats $(0.46) Estimate

Solid Biosciences (NASDAQ:SLDB) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.46) by 17.39 percent. This is a 9.52 percent increase over losses of $(0.42) per share from

Benzinga Newsdesk

PRO
Solid Biosciences Q1 EPS $(0.52) Misses $(0.44) Estimate

Solid Biosciences (NASDAQ:SLDB) reported quarterly losses of $(0.52) per share which missed the analyst consensus estimate of $(0.44) by 18.18 percent. This is a 11.86 percent increase over losses of $(0.59) per share

Benzinga Newsdesk

PRO
Solid Biosciences Q4 EPS $(0.53) Misses $(0.50) Estimate

Solid Biosciences (NASDAQ:SLDB) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(0.50) by 5.79 percent. This is a 47 percent increase over losses of $(1.00) per share from

Benzinga Newsdesk

PRO
Solid Biosciences Q3 EPS $(0.48) Misses $(0.43) Estimate

Solid Biosciences (NASDAQ:SLDB) reported quarterly losses of $(0.48) per share which missed the analyst consensus estimate of $(0.43) by 11.11 percent. This is a 39.24 percent increase over losses of $(0.79) per share

Benzinga Newsdesk

PRO
Solid Biosciences Q2 EPS $(0.42) Beats $(0.53) Estimate

Solid Biosciences (NASDAQ:SLDB) reported quarterly losses of $(0.42) per share which beat the analyst consensus estimate of $(0.53) by 20 percent. This is a 31.15 percent increase over losses of $(0.61) per share from

Benzinga Newsdesk

PRO
Solid Biosciences Q1 EPS $(0.59) Misses $(0.56) Estimate

Solid Biosciences (NASDAQ:SLDB) reported quarterly losses of $(0.59) per share which missed the analyst consensus estimate of $(0.56) by 5.36 percent. This is a 7.81 percent increase over losses of $(0.64) per share from

Benzinga Newsdesk